Hefei Meiya Optoelectronic Technology (SZ:002690)2022-12-07 08:41Group 1: Competitive Advantages - The company's oral CT diagnostic machines are independently developed, possessing complete intellectual property rights, and offer lower radiation and higher clarity compared to similar products domestically and internationally [2][3]. - The company's after-sales service is quick to respond, more convenient, and cost-effective, with product prices being more competitive than foreign counterparts [3]. Group 2: Medical Field Planning - The company has a three-step plan for the medical field: short-term focus on high-end specialized imaging equipment like oral and skeletal CTs to replace imports; mid-term research in cancer detection and treatment; and long-term collaboration with international medical companies to develop more domestic medical products [3][4]. Group 3: Market Response and New Products - Following the launch of the new generation color selection machine equipped with advanced CCD technology and big data internet technology, the product received positive feedback and strong sales performance from both domestic and international clients [4]. - The aflatoxin detection equipment has entered the pilot testing stage and will be gradually introduced to the market after continuous upgrades [4]. Group 4: Future Mergers and Acquisitions - Since transitioning to the medical field in 2012, the company has developed mature high-end oral imaging products and plans to continue investing in this area, with potential for mergers or restructuring to enhance core competitiveness and expand market reach [4]. Group 5: Export Growth Trends - The company has significantly increased its overseas exports, with products now reaching over 80 countries and regions, and expects to maintain rapid growth in export business, with color selection machine export revenue projected to account for over half of total revenue in the future [5].